December 02, 2016 3:17 PM ET

Pharmaceuticals

Company Overview of Par Pharmaceutical Companies Inc.

Key Executives for Par Pharmaceutical Companies Inc.

NameBoard RelationshipsTitleAge
Paul V. Campanelli 15 RelationshipsChief Executive Officer and Director54
Antonio R. Pera No RelationshipsPresident59
Michael A. Tropiano 3 RelationshipsChief Financial Officer, Executive Vice President, Treasurer and Director58
Barry J. Gilman No RelationshipsSenior Vice President and General Counsel of Generics--

Par Pharmaceutical Companies Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Paul V. Campanelli 15 RelationshipsEndo International plc54
Michael A. Tropiano 3 RelationshipsPar Pharmaceutical Holdings, Inc.58
Thomas J. Haughey 3 RelationshipsPar Pharmaceutical Holdings, Inc.52
Patrick G. LePore 22 RelationshipsPar Pharmaceutical, Inc.61
View All Board Members

Par Pharmaceutical Companies Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$870.9K
870.9K
394.0K
Bonus
Not meaningful
Total Short Term Compensation$870.9K
870.9K
579.2K
Total Value of Options
13.6M
Compensation as of Fiscal Year
Par Pharmaceutical Companies Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Boston Therapeutics, Inc. Appoints Carl W. Rausch as Director
December 01, 2016 6:17 PM ET
MeriCal, LLC Appoints Jeremy Bartos as Director of Sales and Product Development
December 01, 2016 3:03 PM ET
EuroPharma, Inc. Appoints Alexander George Panossian as Consultant, and Research and Science Director for Product Development as an Expert in Herbal Products
December 01, 2016 2:30 PM ET
Akashi Therapeutics Appoints Alka Batycky to Executive Vice-President, Portfolio Management and Operations
December 01, 2016 1:03 PM ET
Eisai Inc. Appoints Rebecca Jolley as Senior Vice President Americas Commercial
December 01, 2016 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Par Pharmaceutical Companies Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.